Fosmidomycin: Difference between revisions
m Protected "Fosmidomycin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +) |
||
| Line 25: | Line 25: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Fosmidomycin''' is an [[antibiotic]] that specific inhibits [[DXP reductoisomerase]], a key enzyme in the [[non-mevalonate pathway]]. It is a structural analogue of [[2-C-methyl-D-erythrose 4-phosphate]]. It inhibits the [[E. coli]] enzyme with a KI value of 38 nM (4). | '''Fosmidomycin''' is an [[antibiotic]] that specific inhibits [[DXP reductoisomerase]], a key enzyme in the [[non-mevalonate pathway]]. It is a structural analogue of [[2-C-methyl-D-erythrose 4-phosphate]]. It inhibits the [[E. coli]] enzyme with a KI value of 38 nM (4). | ||
| Line 36: | Line 36: | ||
[[de:Fosmidomycin]] | [[de:Fosmidomycin]] | ||
[[Category:Antibiotics]] | [[Category:Antibiotics]] | ||
Latest revision as of 02:50, 9 August 2012
| File:Fosmidomycin.svg | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C4H10NO5P |
| Molar mass | 183.100 g/mol |
|
WikiDoc Resources for Fosmidomycin |
|
Articles |
|---|
|
Most recent articles on Fosmidomycin Most cited articles on Fosmidomycin |
|
Media |
|
Powerpoint slides on Fosmidomycin |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Fosmidomycin at Clinical Trials.gov Clinical Trials on Fosmidomycin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Fosmidomycin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Fosmidomycin Discussion groups on Fosmidomycin Patient Handouts on Fosmidomycin Directions to Hospitals Treating Fosmidomycin Risk calculators and risk factors for Fosmidomycin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Fosmidomycin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Fosmidomycin is an antibiotic that specific inhibits DXP reductoisomerase, a key enzyme in the non-mevalonate pathway. It is a structural analogue of 2-C-methyl-D-erythrose 4-phosphate. It inhibits the E. coli enzyme with a KI value of 38 nM (4).
See also
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antibiotics
- Inhibitors